Doccla Raises $46 Million for European Expansion of Home Healthcare Tech

Doccla, a startup, has just raised $46 million. They are expanding into Europe. Doccla utilizes technology to manage patients at home, thereby reducing the need for hospital visits. They gained significant traction during the Covid-19 pandemic by keeping people out of hospitals.

Their system incorporates monitoring devices and an app. Data is transmitted directly to doctors. Alerts assist overburdened staff and reassure patients. Doccla enters new markets by securing customers first. They are also involved in drug research, substituting clinic visits with remote monitoring.

Competition is intense. Doccla distinguishes itself by being device-agnostic and offering simple, yet effective technology. They facilitate communication between patients and doctors through app messaging and video calls.

Explanation of Terms:

• Device-agnostic: The technology is compatible with various devices, not limited to one specific type.
• CROs (Contract Research Organizations): Companies that offer research services on a contract basis to the pharmaceutical and biotechnology industries.